Our Mission
Over the past few decades, conjugation chemistry has advanced dramatically, enabling applications across nearly every area of the life sciences. Scientists can now design and build powerful new molecules by modifying existing biomolecules. Yet many of these innovations remain in the research lab.
A key challenge is the gap between those who can create bioconjugates and those who need to use them at scale. This disconnect is driven by limited robustness and standardization in commonly used chemistries, the inherent complexity of biomolecules, and persistent difficulties in bioconjugate analysis and purification. Even when a bioconjugate is successfully produced, it may fall short in real-world applications due to issues such as poor solubility, reduced activity, or aggregation and precipitation.
These barriers underscore the need for next-generation crosslinkers and linkers that can reliably tune bioconjugate properties.
CellMosaic’s mission is to be a global leader in delivering transofrmative bioconjugation solutions through our proprietary AqueaThether® (AqT®) Technologies and Advanced Conjugation Processes.
Our goal is to make high-quality, innovative, and advanced bioconjugates broadly accessible—through reagents and ready-to-use kits—and to help customers accelerate development of bioconjugate drug candidates, detection agents, and research tools via custom bioconjugation services, contract manufacturing, and strategic partnerships.